- Home
- JANX vs GSBC Comparison
JANX vs GSBC Comparison
Compare JANX & GSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JANX | GSBC |
|---|---|---|
| Founded | 2017 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 975.7M | 870.9M |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | JANX | GSBC |
|---|---|---|
| Price | $16.62 | $78.81 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 1 |
| Target Price | $47.00 | ★ $65.00 |
| AVG Volume (30 Days) | ★ 853.7K | 74.2K |
| Earning Date | 05-08-2026 | 04-15-2026 |
| Dividend Yield | N/A | ★ 2.54% |
| EPS Growth | N/A | ★ 17.68 |
| EPS | N/A | ★ 2.99 |
| Revenue | ★ $10,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.56 |
| P/E Ratio | ★ N/A | $26.55 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.12 | $53.76 |
| 52 Week High | $35.34 | $82.91 |
Technical Indicators
Market Signals| Indicator | JANX | GSBC |
|---|---|---|
| Relative Strength Index (RSI) | 42.35 | 45.54 |
| Support Level | $13.09 | $76.29 |
| Resistance Level | $16.68 | $82.19 |
| Average True Range (ATR) | 0.80 | 1.55 |
| MACD | -0.40 | -0.05 |
| Stochastic Oscillator | 10.77 | 36.05 |
Price Performance
Historical ComparisonAbout JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. Through its subsidiaries, the company mainly offers a variety of banking and banking-related services, such as accepting deposits, granting loans and advances, offering mobile banking services, issuing debit and credit cards, safe deposit boxes, ATM facilities, and other related products and services. These services are offered through full-service retail banking offices and loan production offices located across different states in the U.S., including Missouri, Iowa, Kansas, Minnesota, Nebraska, Arkansas, and others.